Fresenius Medical Care AG (Fresenius Medical Care AG) Total Inventories : $2,376 Mil (As of Dec. 2023)

View and export this data going back to 1996. Start your Free Trial

What is Fresenius Medical Care AG Total Inventories?

Fresenius Medical Care AG's total inventories for the quarter that ended in Dec. 2023 was $2,376 Mil. Fresenius Medical Care AG's average total inventories from the quarter that ended in Sep. 2023 to the quarter that ended in Dec. 2023 was $2,418 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Fresenius Medical Care AG's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was $-27.72.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Fresenius Medical Care AG's Days Inventory for the three months ended in Dec. 2023 was 55.60.

Inventory Turnover measures how fast the company turns over its inventory within a year. Fresenius Medical Care AG's Inventory Turnover for the quarter that ended in Dec. 2023 was 1.64.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Fresenius Medical Care AG's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.44.

Fresenius Medical Care AG Total Inventories Historical Data

The historical data trend for Fresenius Medical Care AG's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresenius Medical Care AG Total Inventories Chart

Fresenius Medical Care AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Inventories

Get a 7-Day Free Trial

1,848.09

2,305.73

2,302.84

2,432.43

2,376.42

Fresenius Medical Care AG Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Inventories	Get a 7-Day Free Trial															2,432.43	2,492.54	2,530.27	2,458.80	2,376.42

Fresenius Medical Care AG Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Fresenius Medical Care AG (NYSE:FMS) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Fresenius Medical Care AG's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is

	Net-Net Working Capital Per Share (Q: Dec. 2023 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(1679.147	+	0.75 * 4020.736	+	0.5 * 2376.418	-	20832.359
-	0	-	1315.457)	/	586.827
=	-27.72

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Fresenius Medical Care AG's Days Inventory for the three months ended in Dec. 2023 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2023 )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
	=	2417.6105	/	3967.536	*	365 / 4
	=	55.60

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Fresenius Medical Care AG's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2023 )	/	Average Total Inventories (Q: Dec. 2023 )
	=	3967.536	/	2417.6105
	=	1.64

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Fresenius Medical Care AG's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	2417.6105	/	5439.352
	=	0.44

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Fresenius Medical Care AG Total Inventories Related Terms

Thank you for viewing the detailed overview of Fresenius Medical Care AG's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Fresenius Medical Care AG (Fresenius Medical Care AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius Medical Care AG (NYSE:FMS) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

FMCQF:USA FME:Italy FMEd:UK 0H9X:UK FME:Germany FMEA:Germany FME:Germany FME:Germany FMEA:Germany FME:Germany FMSC34:Brazil FME:Austria

Address

Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352

Website

https://www.freseniusmedicalcare.com

Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of December 2022. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.

Executives

Helen Pring Giza

Board of Directors